India reported 24 lakh TB cases last year, despite a government program launched in 2018 aiming to eliminate TB by 2025. This conversation examines critical advancements, including innovative diagnostics, improved treatment regimens, and public-private partnerships. Host Vikas Dandekar is joined by a distinguished panel comprising Dr. Urvashi Singh, Deputy Director General (TB) from the Ministry of Health and Family Welfare; Dr. Randeep Guleria, Former Director of AIIMS and a public health advocate; Dr. Alpa Dalal, Head of Pulmonary Medicine at Jupiter Hospital and Honorary Chest Physician at Sewri TB Hospital, Mumbai; and Mr. Sriram Natarajan, Director and CEO of Molbio Diagnostics. Together, they address key challenges such as stigma, treatment adherence, and the role of nutrition in recovery. Learn how India is leveraging technology, community involvement, and government initiatives to tackle one of its most pressing public health challenges. What progress has been made, where do we stand, and what’s next in the fight against tuberculosis? Tune in to find out.

Check out other interesting episodes from the host like: India’s Space Odyssey 2025, How will the H-1B furore pan out?, Building India’s $30 Trillion Future By 2047, Mint Street’s New Maestro, Explaining the Food Inflation Debate, India’s Big Dubai Probe and more!

You can follow Anirban Chowdhury on his social media: Twitter and Linkedin

Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

See omnystudio.com/listener for privacy information.

India vs TB: Where are we at?

The Morning Brief

India vs TB: Where are we at?